1. Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia. Issue 5 (October 2018) Authors: Hard, Marjie L.; Wehr, Angela Y.; Du, Yangchun; Weiden, Peter J.; Walling, David; von Moltke, Lisa Journal: Journal of clinical psychopharmacology Issue: Volume 38:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. F27. EFFICACY OF MONTHLY EXTENDED-RELEASE RISPERIDONE INJECTIONS (RBP-7000) FOR THE TREATMENT OF SCHIZOPHRENIA: AN ANALYSIS OF INDIVIDUAL PANSS ITEMS. (9th April 2019) Authors: Andorn, Anne; Graham, Jay; Fava, Maurizio; Csernansky, John; Newcomer, John W; Walling, David; Shinde, Sunita; Muma, Gilbert; Heidbreder, Christian Journal: Schizophrenia bulletin Issue: Volume 45(2019)Supplement 2 Page Start: S264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. T66. PSYCHOMETRIC VALIDATION OF A NOVEL PATIENT-REPORTED OUTCOME MEASURE FOR ASSESSING PATIENTS' SUBJECTIVE EXPERIENCE OF COGNITIVE IMPAIRMENT OF SCHIZOPHRENIA (PRECIS). (1st April 2018) Authors: Rosen, Raymond; Trudeau, Jeremiah; Silverstein, Steven; Henderson, David; Smith, Adam; Walling, David; Garcia, Miguel; Davis, Bethany; Derogatis, Leonard; Sand, Michael Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S43. A PROOF-OF-MECHANISM STUDY OF THE PDE10 INHIBITOR RG7203 IN PATIENTS WITH PROBING REWARD FUNCTIONS WITH IMAGING AND BEHAVIORAL APPROACHES. (1st April 2018) Authors: Umbricht, Daniel; Dukart, Jürgen; Abt, Markus; Tamburri, Paul; Chatham, Chris; Frank, Michael; Collins, Anne; Walling, David; Mofsen, Rick; Gruener, Daniel; Gertsik, Lev; Sevigny, Jeffrey Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia. (25th February 2022) Authors: Davidson, Michael; Saoud, Jay; Staner, Corinne; Noel, Nadine; Werner, Sandra; Luthringer, Elisabeth; Walling, David; Weiser, Mark; Harvey, Philip D; Strauss, Gregory P; Luthringer, Remy Journal: Schizophrenia bulletin Issue: Volume 48:Number 3(2022) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The Value of an Incomplete Degree: Heterogeneity in the Labor Market Benefits of College Non-Completion. (6th June 2020) Authors: Giani, Matt S.; Attewell, Paul; Walling, David Journal: Journal of higher education Issue: Volume 91:Number 4(2020) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combining Physically Based Modeling and Deep Learning for Fusing GRACE Satellite Data: Can We Learn From Mismatch?. Issue 2 (10th February 2019) Authors: Sun, Alexander Y.; Scanlon, Bridget R.; Zhang, Zizhan; Walling, David; Bhanja, Soumendra N.; Mukherjee, Abhijit; Zhong, Zhi Journal: Water resources research Issue: Volume 55:Issue 2(2019) Page Start: 1179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S35. THE PLACEBO CONUNDRUM: MITIGATING THE RESPONSE AT THE SITE LEVEL. (18th May 2020) Authors: Hassman, Howard; Cohen, Elan; Walling, David; Wyka, Katarzyna; Grindell, Vera; Glass, Steven; Ball, Roberta; Styczynski, John; Lobb, Jaclyn; Hazzard, Dakota; Joseph, Ashok; Ereshefsky, Larry Journal: Schizophrenia bulletin Issue: Volume 46(2020)Supplement 1 Page Start: S45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 167 Randomized, Double-Blind, Active-Controlled Study of Starting Aripiprazole Lauroxil with 1-Day Initiation in Acutely Ill Patients with Schizophrenia. (April 2020) Authors: Weiden, Peter J.; Claxton, Amy; Du, Yangchun; Yagoda, Sergey; Walling, David; Kunovac, Jelena Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 146 Efficacy and Safety of the Asenapine Transdermal Patch, HP-3070, for Schizophrenia: A Phase 3, Randomized, Placebo-Controlled, Inpatient Study. (April 2020) Authors: Citrome, Leslie; Walling, David; Zeni, Courtney; Komaroff, Marina; Park, Alexandra Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗